These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9089560)

  • 1. Effects of hormone replacement therapy on serum amyloid P component in postmenopausal women.
    Hashimoto S; Katou M; Dong Y; Murakami K; Terada S; Inoue M
    Maturitas; 1997 Mar; 26(2):113-9. PubMed ID: 9089560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Change of serum amyloid P component concentrations in women].
    Katou M
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):481-7. PubMed ID: 8754388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of sex steroids on serum amyloid P-component (female protein) in rats].
    Hashimoto S; Kato M; Dong Y; Terada S; Inoue M
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Oct; 47(10):1041-7. PubMed ID: 8522881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum amyloid P component regulation by sex steroids in rats.
    Hashimoto S; Migita S
    Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):89-97. PubMed ID: 2139536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women.
    Wide L; Naessén T; Phillips DJ
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):59-64. PubMed ID: 7889633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences.
    Genazzani AR; Petraglia F; Bernardi F; Casarosa E; Salvestroni C; Tonetti A; Nappi RE; Luisi S; Palumbo M; Purdy RH; Luisi M
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2099-103. PubMed ID: 9626145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydroepiandrosterone for women in the peri- or postmenopausal phase.
    Scheffers CS; Armstrong S; Cantineau AE; Farquhar C; Jordan V
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD011066. PubMed ID: 25879093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of postmenopausal estrogen replacement on circulating androgens.
    Casson PR; Elkind-Hirsch KE; Buster JE; Hornsby PJ; Carson SA; Snabes MC
    Obstet Gynecol; 1997 Dec; 90(6):995-8. PubMed ID: 9397118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of serum amyloid P component from human aortic atherosclerotic lesions.
    Li XA; Hatanaka K; Ishibashi-Ueda H; Yutani C; Yamamoto A
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):252-7. PubMed ID: 7749834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women].
    Alfonso Cano C; Vez García MD; García Urruticoechea P; Tornel Osorio PL; Canteras Jordana M; Abellán Alemán J
    An Med Interna; 2003 Feb; 20(2):70-4. PubMed ID: 12703158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial.
    Strickler R; Stovall DW; Merritt D; Shen W; Wong M; Silfen SL
    Obstet Gynecol; 2000 Sep; 96(3):359-65. PubMed ID: 10960626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of coronary flow velocity reserve by gender, menstrual cycle and hormone replacement therapy.
    Hirata K; Shimada K; Watanabe H; Muro T; Yoshiyama M; Takeuchi K; Hozumi T; Yoshikawa J
    J Am Coll Cardiol; 2001 Dec; 38(7):1879-84. PubMed ID: 11738288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
    Schlegel W; Petersdorf LI; Junker R; Schulte H; Ebert C; Von Eckardstein A
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of reproductive hormonal dynamics in the perimenopause.
    Santoro N; Brown JR; Adel T; Skurnick JH
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1495-501. PubMed ID: 8636357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
    Kanaya AM; Herrington D; Vittinghoff E; Lin F; Grady D; Bittner V; Cauley JA; Barrett-Connor E;
    Ann Intern Med; 2003 Jan; 138(1):1-9. PubMed ID: 12513038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal changes in serum cytokine levels and hormone replacement therapy.
    Kamada M; Irahara M; Maegawa M; Ohmoto Y; Takeji T; Yasui T; Aono T
    Am J Obstet Gynecol; 2001 Feb; 184(3):309-14. PubMed ID: 11228479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of serum amyloid P by enzyme-linked immunosorbent assay.
    Saïle R; Kandoussi A; Deveaux M; Descamps J; Hachulla E; Cachera C
    Clin Chem; 1991 Oct; 37(10 Pt 1):1742-5. PubMed ID: 1914177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.